A Pilot Study into the Use of Intraoperative Indocyanine Green Fluorescence Angiography in Young Infants & Neonates
- Conditions
- Surgical gastrointestinal disordersDisorders of the gastrointestinal system requiring surgery1001803110017998
- Registration Number
- NL-OMON56951
- Lead Sponsor
- niversitair Medisch Centrum Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
1. Written informed consent is obtained by both patient*s parents or legal
guardians (as applicable);
2. Patient is a neonate (< 1 month of age) or young infant (<3 months of age);
3. Patient is suffering from necrotizing enterocolitis, intestinal atresia,
malrotation or spontaneous intestinal perforation;
4. Patient requires laparotomy for management of the disease.
General exclusion criteria
1. Patient is suffering from clinically significant (treatment necessary)
hyperbilirubinemia;
2. Patient is suffering from thyroid or liver disease;
3. Patient is allergic to the active substance indocyanine green or sodium
iodide or iodine;
4. Patient has abdominal wall defects;
5. Patient can be treated non-surgically;
6. During the preoperative multidisciplinary meeting with the team, including
the pediatric anesthetist, patient is deemed not stable enough hemodynamically
to perform the ICG-FA measurements
Intra-operative exclusion criterium
7. Patient is assessed unstable by operating team intraoperatively.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method